Progress in analyzing protein-protein interactions - PowerPoint PPT Presentation

1 / 44
About This Presentation
Title:

Progress in analyzing protein-protein interactions

Description:

Title: PowerPoint Presentation Author: Enterprise IG Last modified by: asnorhana Created Date: 4/10/2002 9:45:09 PM Document presentation format: On-screen Show – PowerPoint PPT presentation

Number of Views:65
Avg rating:3.0/5.0
Slides: 45
Provided by: Ente61
Category:

less

Transcript and Presenter's Notes

Title: Progress in analyzing protein-protein interactions


1
Progress in analyzing protein-protein
interactions Chia Jer-ming Prasanna R Kolatkar
LinKui(BNU)
2
Structure guys
  • Paaventhan Palasingam
  • Jeremiah S Joseph

3
Protein Functional Dbase Protein
Interactions Rosetta Stone Text
Information/Dbase MS/yeast two-hybrid
4
(No Transcript)
5
(No Transcript)
6
Value of Kleisli/K1
Data doesnt have to be re-stored locally in a
specific format Efficient Flexible
7
Protein-Protein Interaction Database (PPiDB v
1.0)                                            
                                                  
           
8
  •    Protein-Protein Interaction Queries
  •    Query Interactions
  • by Species 
  • by Protein
  • by Text Search engine.

9
  • P V PROTEIN KINASE 1 PKGA lt-
    P34101Also called EC 2.7.1.-, FRAGMENT.From
    Dictyostelium discoideum.Interacting domain
    Eukaryotic protein kinase domain.

10
  •    Information of Eukaryotic protein kinase
    domain
  •    DB links Pfam PubMed Swissprot PDB
    Genbank DIP
  •    Interacting with 55 domains
  • Actin
  • Adenylate and Guanylate cyclase catalytic domain
  • Ank repeat
  • BTK motif
  • C2 domain
  • CNH domain
  • Cadherin domain
  • Cyclic nucleotide-binding domain
  • Death domain
  • DnaJ domain
  • Double-stranded RNA binding motif
  • EF hand
  • EGF-like domain
  • F5/8 type C domain
  • FHA domain

11
  •    Interacting domains Eukaryotic protein
    kinase domain ltgt Death domain
  •    Shared proteins
  • death-associated protein kinase 1, also EC
    2.7.1.-, DAP KINASE 1, from Homo sapiens
  • probable serine/threonine protein kinase pelle,
    also EC 2.7.1.37, from Drosophila melanogaster
  • serine/threonine protein kinase rip, also EC
    2.7.1.-, CELL DEATH PROTEIN RIP, RECEPTOR
    INTERACTING PROTEIN, from Mus musculus
  • serine/threonine protein kinase rip, also EC
    2.7.1.-, CELL DEATH PROTEIN RIP, RECEPTOR
    INTERACTING PROTEIN, from Homo sapiens
  •    Protein pairs
  • Species Bovine - Bos taurus
  • activin receptor type i precursor ltgt fasl
    receptor precursor
  • activin receptor type ii precursor ltgt fasl
    receptor precursor
  • angiopoietin 1 receptor precursor ltgt fasl
    receptor precursor

12
  • P V PROTEIN KINASE 1 PKGA lt-
    P34101Also called EC 2.7.1.-, FRAGMENT.From
    Dictyostelium discoideum.Interacting domain
    Eukaryotic protein kinase domain.

13
(No Transcript)
14
  •    Interactions
  • P34101protein kinase 1
  • ltgt Q021581-phosphatidylinositol-4,5-bisphosphate
    phosphodiesterase
  • ltgt P05987camp-dependent protein kinase
    regulatory chain
  • ltgt P08796contact site a protein precursor
  • ltgt P34125myosin heavy chain kinase
  • ltgt P42527myosin heavy chain kinase a
  • ltgt P90648myosin heavy chain kinase b
  • ltgt P22467myosin ia heavy chain
  • ltgt P34092myosin ib heavy chain
  • ltgt P42522myosin ic heavy chain
  • ltgt P34109myosin id heavy chain
  • ltgt Q03479myosin ie heavy chain
  • ltgt P54695myosin if heavy chain
  • ltgt P54696myosin ih heavy chain
  • ltgt P08799myosin ii heavy chain, non muscle
  • ltgt P54697myosin ij heavy chain
  • ltgt P13833myosin regulatory light chain
  •    Interactions
  • P34101protein kinase 1
  • ltgt Q021581-phosphatidylinositol-4,5-bisphosphate
    phosphodiesterase
  • ltgt P05987camp-dependent protein kinase
    regulatory chain
  • ltgt P08796contact site a protein precursor
  • ltgt P34125myosin heavy chain kinase
  • ltgt P42527myosin heavy chain kinase a
  • ltgt P90648myosin heavy chain kinase b
  • ltgt P22467myosin ia heavy chain
  • ltgt P34092myosin ib heavy chain
  • ltgt P42522myosin ic heavy chain
  • ltgt P34109myosin id heavy chain
  • ltgt Q03479myosin ie heavy chain
  • ltgt P54695myosin if heavy chain
  • ltgt P54696myosin ih heavy chain
  • ltgt P08799myosin ii heavy chain, non muscle
  • ltgt P54697myosin ij heavy chain
  • ltgt P13833myosin regulatory light chain
  • Interactions
  • P34101protein kinase 1
  • ltgt Q021581-phosphatidylinositol-4,5-bisphosphate
    phosphodiesterase
  • ltgt P05987camp-dependent protein kinase
    regulatory chain
  • ltgt P08796contact site a protein precursor
  • ltgt P34125myosin heavy chain kinase
  • ltgt P42527myosin heavy chain kinase a
  • ltgt P90648myosin heavy chain kinase b
  • ltgt P22467myosin ia heavy chain
  • ltgt P34092myosin ib heavy chain
  • ltgt P42522myosin ic heavy chain
  • ltgt P34109myosin id heavy chain
  • ltgt Q03479myosin ie heavy chain
  • ltgt P54695myosin if heavy chain
  • ltgt P54696myosin ih heavy chain
  • ltgt P08799myosin ii heavy chain, non muscle
  • ltgt P54697myosin ij heavy chain
  • ltgt P13833myosin regulatory light chain





















15
Scoring System
Computational Identification Weak Same keywords
Moderate Experimental evidence from DIP or
elsewhere Good References in literature
relating names of proteins Good More than 1
support Strong
16
PPDB Current Status Putative Filtered 753508
350819
17
Christian von Mering, Roland Krause, Berend
Snel, Michael Cornell, Stephen G. Oliver,
Stanley Fields Peer Bork NATURE VOL 417 23
MAY 2002
18

Evolutionary Relationships Functional
Relationships Putative Drug Targets
19
Current BIND Database Statistics DatabaseRecord
Count Interaction Database 20000 Biomolecu
lar Pathway Database 8 Molecular Complex
Database 851 Organisms represented 12 GI
Database 4651 DI Database 0 Publication
Database 428
20
BIND Interactions RAS-GTP active form of RAS
bound to GTP RAF Y2H Homo sapiens
21
DIP DATABASE STATISTICS Number of
proteins 6963 Number of organisms 113 Number
of interactions 18059
22
Improving Quality
  • Integrating high quality structural data
  • Separating interaction categories
  • Decreasing false positives

23
Using 3-D data
  • 3-D data from PDB (Thornton,Ofran and Rost)
  • Inter-domain interactions distances and
    comparison between sequence separation
  • Also do for inter-protein interactions

24
Better structural analysis
  • Careful analysis of the structural data needed
  • Transient,Permanent,homo-oligomers,hetero-oligomer
    s
  • ML could be highly useful with better
    categorization

25
  • Sarah Teichman domains separated by 30 residues
    are the ones that have interaction

26
  • Testing the rule
  • Need a good data set to test the rule

27
X-ray crystallography
  • Structural Information important for detailed and
    mechanistic understanding
  • Least populated data
  • Highly useful when merged with lots of functional
    information

28
(No Transcript)
29
(No Transcript)
30
  • PFAM/PDB
  • Single chain with multiple domains including
    complexes
  • Only use non-redundant chains
  • calculate distances between the domains

31
  • Criteria
  • 6A
  • Number of contacts you can choose
  • Between domains
  • If xtal contact omit

32
  • What did we see with the 1273 chains
  • Teichman rule basically obeyed
  • Exceptions
  • Binding proteins
  • SH3 proteins

33
(No Transcript)
34
Applying PPDB
  • PPDB can be used to predict a set of interacting
    proteins.
  • Intersection with Y2H studies and other methods
  • Help direct structural genomics of complexes and
    improve PPDB

35
Thermatoga structural genomics
  • Great model to look at a large set of complexes
  • Will be useful for looking at interactions in
    other systems
  • Can be used to build a database of interacting
    motifs

36
Thermatoga current state
  • Crystallized several hundred and scores of
    structures
  • Initial Yeast two hybrid data
  • Large scale-up facilities

37
Thermatoga Y2H vs PPDB
  • 15 overlap
  • Improving

38
TFs
  • Stem Cell totipotency TFs
  • Hep B TFs
  • ER TFs

39
Support
  • Mass Spec
  • MA
  • Structure
  • Other info

40
Genomic analysis
  • Careful genomic data analysis can greatly
    accelerate discovery (i.e regulatory networks)

41
  • Pombe kinase
  • What are the possible interactions?

42
(No Transcript)
43
Pombe Yeast Score E-val Human Score E-val
BUB1 BUB1 231 2E-63 BUB1 137 2E-35
BYR1 MKK1 195 9E-53 MAP2K2 238 1E-65
BYR2 STE11 292 5E-82 MAP3K3 216 3E-59
CDC2 CDC28 377 1E-107 CDK2 390 1E-111
CDC7 CDC15 206 3E-56 MAP3K8 192 7E-52
CDR1 KCC4 229 5E-63 BRSK2 201 1E-54
CDR2 HSL1 246 5E-68 BRSK1 255 5E-71
CDS1 RAD53 228 9E-63 CHK2 174 1E-46
CEK1 RIM15 209 6E-57 MAST3 160 2E-42
CHK1 CHK1 218 1E-59 CHK1 189 3E-51
CKA1 CKA2 361 1E-103 CK2a1 390 1E-111
CKI1 YCK1 395 1E-113 CK1g2 344 1E-97
CKI2 YCK2 405 1E-116 CK1g3 338 6E-96
CKI3 YCK3 342 5E-97 CK1g1 331 8E-94
CMK1 CMK1 217 2E-59 CaMK1a 244 1E-67
CMK2 RCK1 245 8E-68 CaMK1d 210 2E-57
CRK1 KIN28 317 2E-89 CDK7 304 1E-85
DSK1 SKY1 230 5E-63 MSSK1 205 2E-55
FIN1 KIN3 231 2E-63 NEK2 229 4E-63
HHP1 HRR25 424 1E-122 CK1e 440 1E-126
KIN1 KIN2 331 1E-93 MARK3 233 3E-64
KSG1 PKH1 294 1E-82 PDK1 294 1E-82
LKH1 KNS1 273 5E-76 CLK2 296 3E-83
MEK1 MEK1 181 1E-48 DCAMKL3 170 2E-45
MKH1 BCK1 326 2E-92 MAP3K2 187 2E-50
MPH1 MPS1 233 2E-64 TTK 238 7E-66
NAK1 KIC1 282 4E-79 MST3 234 2E-64
ORB6 CBK1 448 1E-129 NDR2 374 1E-106
44
(No Transcript)
45
Which way is right?
  • Strong et al Eisenberg Dec 15 NAR Functional
    linkage M. Tuberculosis
  • Giot et al.Rothberg Dec 5 Science Drosophila Y2H
Write a Comment
User Comments (0)
About PowerShow.com